Apimeds Pharmaceuticals US (APUS) Prepaid Assets (2023 - 2025)

Apimeds Pharmaceuticals US has reported Prepaid Assets for 3 years, with the latest figure at $48500.0 in Q4 2025.

• For the quarter ending Q4 2025, Prepaid Assets rose 405.1% year-over-year to $48500.0; the trailing twelve-month figure through Dec 2025 stood at $48500.0 (up 405.1% YoY), and the FY2025 full-year result was $48500.0, up 405.1% from the prior year.
• Prepaid Assets for Q4 2025 stood at $48500.0, down from $344990.0 in the prior quarter.
• The five-year high for Prepaid Assets was $1.6 million in Q2 2025, with the low at $9562.0 in Q1 2025.
• Historically, Prepaid Assets has averaged $339745.8 across 3 years, with a median of $30047.5 in 2023.
• Annual changes were most pronounced in 2024 — Prepaid Assets declined 17.19% — and 2025, when it soared 405.1%.
• Apimeds Pharmaceuticals US's Prepaid Assets stood at $11595.0 in 2023, then decreased by 17.19% to $9602.0 in 2024, then soared by 405.1% to $48500.0 in 2025.
• The last three Prepaid Assets figures came in at $48500.0 (Q4 2025), $344990.0 (Q3 2025), and $1.6 million (Q2 2025), per Business Quant data.